Tension Headache Relief

Product NDC
68016-694
Requested package NDC
68016-694-10
11-digit product format
680160694
Labeler code
68016
Product ID
68016-694_c4fc44bb-668e-468e-8bbf-7800905801df
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen, Caffeine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Chain Drug Consortium
Application
part343
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2007-01-17
Marketing end
0000-00-00
Substance
ACETAMINOPHEN; CAFFEINE
Active strength
500 mg/1; mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage68016-69468016-694-10DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68016-694-10EA - Each68016-694759490e2-6dac-4931-8abd-15c2ee8fd72d12022-06-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DTENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
CAFFEINEACTIVE INGREDIENT3G6A5W338ETENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
ACETAMINOPHENACTIVE MOIETY362O9ITL9DTENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
CAFFEINEACTIVE MOIETY3G6A5W338ETENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UTENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
CROSPOVIDONEINACTIVE INGREDIENT68401960MKTENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
D&C RED NO. 27INACTIVE INGREDIENT2LRS185U6KTENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKTENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8TENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30TENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ATENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
POLYVINYL ALCOHOLINACTIVE INGREDIENT532B59J990TENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
POVIDONESINACTIVE INGREDIENTFZ989GH94ETENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJTENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APTENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
TALCINACTIVE INGREDIENT7SEV7J4R1UTENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPTENSION HEADACHE RELIEF (ACETAMINOPHEN, CAFFEINE) TABLET [CHAIN DRUG CONSORTIUM]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68016-694-10680160694101 BOTTLE in 1 CARTON (68016-694-10) > 100 TABLET, FILM COATED in 1 BOTTLE1 bottle2007-01-170000-00-00NoNoCurrent